Browse by:

Alexion gets new U.S. patents for Soliris

John Stearns |

New Haven-based Alexion Pharmaceuticals Inc. has received three new U.S. patents involving the composition and pharmaceutical formulations of its key rare blood-disorder drug, Soliris, and methods of...

SBA awards CT Innovations grant for $125K

Patricia Daddona |

The U.S. Small Business Administration has awarded Connecticut Innovations Inc. for $125,000 to support technology-driven small businesses.

CT shares in $5.5M data breach settlement with Nationwide

Patricia Daddona |

Connecticut is sharing with other states a $5.5 million settlement with Nationwide Mutual Insurance Company to resolve claims related to a 2012 data breach, state Attorney General George Jepsen said.

Avara to acquire Pfizer Italian facility

John Stearns |

Norwalk-based Avara Pharmaceutical Services said it has has signed an agreement with Pfizer to acquire a sterile manufacturing facility in Liscate, Italy.

New Haven's Melinta merging with N.C.'s Cempra

John Stearns |

New Haven's Melinta Therapeutics said Wednesday that it is merging with North Carolina-based Cempra Inc., a publicly traded company and fellow antibiotics developer.

Back9 successor acquires ball tracing app

Patricia Daddona |

Hartford-based Swing by Swing Golf Inc., a golf mobile app, media and entertainment company, has acquired gottaGolf LLC, a top ball tracer and social app.

TransAct Tech posts 15% profit rise

Patricia Daddona |

Hamden-based software technology firm TransAct Technologies said its profits rose 15 percent in the second quarter, mostly due to growth in the restaurant technology market.

ReadyDock raises $1.9M Series A

Matt Pilon |

West Hartford's ReadyDock, which makes a disinfecting device for cell phones and tablets, disclosed Thursday that it's raised $1.9 million in equity.

Biohaven receives FDA's orphan drug designation for Rett syndrome treatment

John Stearns |

New Haven-based Biohaven Pharmaceutical Holding Co. Ltd. said its investigational compound has been granted orphan drug designation by the U.S. Food and Drug Administration to treat patients with...

Alex's Lemonade Stand Foundation awards $250K grant to Yale researchers for pediatric cancer work

John Stearns | 1

Alex's Lemonade Stand Foundation (ALSF), a nonprofit dedicated to finding cures for children with cancer, has awarded 19 innovation grants to leading pediatric oncologists across the country,...

Copyright 2017 New England Business Media